Trials / Completed
CompletedNCT01384214
Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia
Pilot Study of the Effect of Botulinum Toxin Type A Treatment on Swallowing in Patients With Cervical Dystonia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate swallowing efficiency in patients with cervical dystonia following treatment with botulinum toxin Type A.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | 750 U at Visit 1 |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2011-06-29
- Last updated
- 2011-06-29
Locations
1 site across 1 country: Croatia
Source: ClinicalTrials.gov record NCT01384214. Inclusion in this directory is not an endorsement.